Background illustration for clinical trials search

Lung Cancer Clinical Trials

Browse 2,144 lung cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Evaluation of the F&P Mask, US, 2026

for
Chronic Respiratory Conditions, Obstructive Sleep Apnea (OSA)
Location: St Louis MO
Sponsor: Fisher and Paykel Healthcare

Sex: All

Age: 22+

Code: NCT07826429

Recruiting

A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

for
Urothelial Carcinoma Bladder,
Location: New York NY, Glen Burnie MD, Pittsburgh PA, Orlando FL,
Sponsor: Aktis Oncology, Inc.

Sex: All

Age: 18+

Code: NCT07020117

Phase 1, Recruiting

A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors

for
Cancer
Location: New Haven CT, Lake Success NY, East Brunswick NJ,
Sponsor: IDEAYA Biosciences

Sex: All

Age: 18 - 70+

Code: NCT07540572

Phase 1, Recruiting

Telisotuzumab Vedotin and Osimertinib for the Treatment of Progressive, Incurable, Non Small Cell Lung Cancer

for
Lung Non-Small Cell Carcinoma
Location: Los Angeles CA
Sponsor: Jonsson Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT07323641

Phase 2, Recruiting

A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

for
Advance Solid Tumors
Location: New Have CT, Santa Monica CA
Sponsor: Kivu Bioscience Inc.

Sex: All

Age: 18+

Code: NCT07229313

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Test the Safety and Tolerability of SBO-154 in Patients With Advanced Solid Tumors.

for
Advanced Solid Tumors
Location: New Haven CT, Hinsdale IL, Houston TX, Scottsdale AZ,
Sponsor: Sun Pharma Advanced Research Company Limited

Sex: All

Age: 18+

Code: NCT07042100

Phase 1, Recruiting

Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors

for
Head and Neck Squamous Cell Carcinoma (HNSCC),
Location: New York NY, Columbus OH, Grand Rapids MI,
Sponsor: Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT05985655

Phase 1, Phase 2, Recruiting

On-Trac: An Online Intervention for Cancer Survivors Managing Anxiety

for
Cancer, Survivorship, Anxiety
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT07305740

Recruiting

Hypersight and Ethos In Pediatric Radiotherapy

for
Cancer
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 0 - 18

Code: NCT07528547

Recruiting

Integrated Smartphone Technology to Alleviate Malignant Pain (I-STAMP) Testing

for
Advanced Cancer, Pain
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 21+

Code: NCT06117709

Recruiting

A Study Evaluating the Immunotherapy Treatment for Ovarian Cancer and Other Advanced Malignancies.

for
Ovarian Cancer, Advanced Malignant Solid Tumor
Location: Chicago IL
Sponsor: University of Chicago

Sex: All

Age: 18+

Code: NCT07389239

Phase 1, Phase 2, Recruiting

First-in-Human Study of ADCE-B05 in Patients With Advanced Solid Tumors

for
Solid Tumors (Phase 1)
Location: New Haven CT, Springdale AR, Houston TX
Sponsor: Adcendo ApS

Sex: All

Age: 18+

Code: NCT07362888

Phase 1, Recruiting

A Pilot Randomized Controlled Trial of a Social Network Intervention

for
Advanced Cancer, Older Adults (65 Years and Older),
Location: Rochester NY
Sponsor: University of Rochester

Sex: All

Age: 65+

Code: NCT07393529

Recruiting

DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

for
Solid Tumors
Location: New York NY, Virginia Beach VA, Bethesda MD,
Sponsor: DualityBio Inc.

Sex: All

Age: 18+

Code: NCT06953089

Phase 2, Recruiting

Ultra-Rapid Profiling and Drug Screening for Treatment Selection in Patients With Relapsed or Recurrent Rare Brain Tumors

for
Rare CNS Tumor, FOXR2-activated, BCOR ITD Sarcoma, CNS Sarcoma,
Location: Washington D.C. DC
Sponsor: Adriana Fonseca

Sex: All

Age: 0 - 45

Code: NCT07851636

Recruiting

Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)

for
Non-small Cell Lung Cancer (NSCLC)
Location: Boston MA, New York NY, Montreal, Washington D.C. DC,
Sponsor: Nuvation Bio Inc.

Sex: All

Age: 18+

Code: NCT07154706

Phase 3, Recruiting

Mindfulness Intervention to Reduce Patient Reported Symptoms in Patients With Chronic Graft-Versus-Host Disease

for
Chronic Graft Versus Host Disease,
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT07733141

Recruiting

Shareholder-driven Co-design and Piloting of Spanish Educational Videos About High Yield Pediatric Oncology Topics

for
Pediatric Cancer
Location: Aurora CO
Sponsor: University of Colorado, Denver

Sex: All

Age: 18+

Code: NCT07288476

Recruiting

EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors

for
Advanced Solid Tumors, MSI-H or dMMR Advanced Solid Tumors,
Location: Lake Success NY, New York NY, Morristown NJ, Tamarac FL,
Sponsor: Eikon Therapeutics

Sex: All

Age: 18+

Code: NCT07262619

Phase 1, Phase 2, Recruiting

A Study Evaluating OBI-902 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Houston TX, San Antonio TX, La Jolla CA
Sponsor: OBI Pharma, Inc

Sex: All

Age: 18+

Code: NCT07124117

Phase 1, Phase 2, Recruiting

What is lung cancer?

Lung cancer starts when cells in the airways or lungs grow out of control. About 229,000 Americans will be diagnosed in 2026. There are two main types: non small cell lung cancer, about 85 percent of cases, and small cell lung cancer, which grows and spreads faster and is treated differently. Smoking causes most cases, but 10 to 20 percent happen in people who never smoked, from causes like radon, air pollution, or genetic changes. Most people are diagnosed around age 70.

Two things changed treatment. First, many lung cancers are driven by a single gene change, and pills that target that specific change can control the cancer for years, so tumors are now routinely tested for these changes before treatment starts. Second, immunotherapy works especially well in lung cancer, and some people with advanced disease are alive and well more than five years later. New targeted drugs kept getting approved through 2025, which is why lung cancer has more recruiting trials than any cancer except breast cancer.

Types of lung cancer clinical trials

Who can participate in lung cancer clinical trials?

What causes lung cancer?

Does vaping cause lung cancer?

The stages of lung cancer, and why they matter for trials

How to enroll in a lung cancer clinical trial